Protein Synthesis Assay Kit (ab239725) uses a novel and robust chemical method based on an alkyne containing and cell permeable analog of puromycin, O-Propargyl-puromycin (OP-puro).
Individual kit components also available for purchase with a minimum order of 20 units. Contact us to discuss your needs.
Fluorescent
Suspension cells, Adherent cells
Select an associated product type
Protein Synthesis Assay Kit (ab239725) uses a novel and robust chemical method based on an alkyne containing and cell permeable analog of puromycin, O-Propargyl-puromycin (OP-puro).
Individual kit components also available for purchase with a minimum order of 20 units. Contact us to discuss your needs.
Fluorescent
Suspension cells, Adherent cells
Flow cytometer, Fluorescence microscope
Blue Ice
-20°C
-20°C
-20°C
Protein Synthesis Assay Kit (ab239725) utilizes a novel and robust chemical method based on an alkyne containing and cell permeable analog of puromycin, O-Propargyl-puromycin (OP-puro). Once inside the cell, OP-puro stops translation by forming covalent conjugates with nascent polypeptide chains.
Truncated polypeptides are rapidly turned over by the proteasome and can be detected based on a click reaction with the fluorescent azide. Unlike methionine analogs, OP-puro does not require methionine-free conditions and can be used to label nascent proteins directly in the cell culture.
This product is manufactured by BioVision, an Abcam company and was previously called K459 EZClick™ Global Protein Synthesis Assay Kit (FACS/Microscopy), Green Fluorescence. K459-100 is the same size as the 100 test size of ab239725.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Inhibitory effect of Cycloheximide on nascent polypeptides synthesis.
HeLa (105 cells/ ml) and Jurkat (1X106 cells/ml) cells respectively were pre-treated with vehicle or Cycloheximide for 30 min at 37°C. Subsequently, cells were incubated for additional 30 min with fresh aliquots of media containing either Protein Label or Protein Label and Cycloheximide. Cells were then processed and analyzed by Microscopy and FACS according to the kit protocol. (A) Green fluorescence (upper panel) corresponds to de novo synthesized polypeptides whereas bottom panel shows the inhibitory effect of Cycloheximide on protein biosynthesis. Nuclear staining in both panels confirms that green signal is a result of Protein Label incorporation.
HeLa (105 cells/ ml) and Jurkat (1X106 cells/ml) cells respectively were pre-treated with vehicle or Cycloheximide for 30 min at 37°C. Subsequently, cells were incubated for additional 30 min with fresh aliquots of media containing either Protein Label or Protein Label and Cycloheximide. Cells were then processed and analyzed by Microscopy and FACS according to the kit protocol. (B) FACS analysis of negative control (white), background (Azide only, blue), positive control (Protein Label, green) and Cycloheximide-treated (pink) cell populations. Signal measured in FL-1 channel clearly shows the inhibitory effect of Cycloheximide on nascent polypeptides synthesis.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com